The Oncoprotein and Transcriptional Regulator Bcl-3 Governs Plasticity and Pathogenicity of Autoimmune T Cells

Immunity

Volumn 41, Issue 4, 2014, Pages 555-566

  Tang, Wanhu ^a   Wang, Hongshan ^a   Claudio, Estefania ^a   Tassi, Ilaria ^a   Ha, Hye lin ^a   Saret, Sun ^a   Siebenlist, Ulrich ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ONCOPROTEIN; PROTEIN BCL 3; RETINOID RELATED ORPHAN RECEPTOR GAMMA; HOMEODOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTO-ONCOGENE PROTEIN BCL-3; RAG-1 PROTEIN; TRANSCRIPTION FACTOR;

ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL TRANSFER; COLITIS; CONTROLLED STUDY; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; PATHOGENICITY; PLASTICITY; T LYMPHOCYTE; TH1 CELL; TH17 CELL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; TRANSPLANTATION;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; COLITIS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HOMEODOMAIN PROTEINS; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B P50 SUBUNIT; NF-KAPPA B P52 SUBUNIT; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PROTO-ONCOGENE PROTEINS; TH1 CELLS; TH17 CELLS; TRANSCRIPTION FACTORS;

EID: 84908137452     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.09.017     Document Type: Article

References (43)

1. Ahern P.P., Schiering C., Buonocore S., McGeachy M.J., Cua D.J., Maloy K.J., Powrie F. Interleukin-23 drives intestinal inflammation through direct activity on Tcells. Immunity 2010, 33:279-288.
2. Bene L., Falus A., Baffy N., Fulop A.K. Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease. Pathol. Oncol. Res. 2011, 17:463-472.
3. Bours V., Franzoso G., Azarenko V., Park S., Kanno T., Brown K., Siebenlist U. The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers. Cell 1993, 72:729-739.
4. Codarri L., Gyülvészi G., Tosevski V., Hesske L., Fontana A., Magnenat L., Suter T., Becher B. RORγt drives production of the cytokine GM-CSF in helper Tcells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011, 12:560-567.
5. El-Behi M., Ciric B., Dai H., Yan Y., Cullimore M., Safavi F., Zhang G.X., Dittel B.N., Rostami A. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 2011, 12:568-575.
6. Feng T., Wang L., Schoeb T.R., Elson C.O., Cong Y. Microbiota innate stimulation is a prerequisite for Tcell spontaneous proliferation and induction of experimental colitis. J.Exp. Med. 2010, 207:1321-1332.
7. Feng T., Qin H., Wang L., Benveniste E.N., Elson C.O., Cong Y. Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production. J.Immunol. 2011, 186:6313-6318.
8. Fransen K., Visschedijk M.C., van Sommeren S., Fu J.Y., Franke L., Festen E.A., Stokkers P.C., van Bodegraven A.A., Crusius J.B., Hommes D.W., et al. Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease. Hum. Mol. Genet. 2010, 19:3482-3488.
9. Franzoso G., Bours V., Park S., Tomita-Yamaguchi M., Kelly K., Siebenlist U. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Nature 1992, 359:339-342.
10. Franzoso G., Carlson L., Scharton-Kersten T., Shores E.W., Epstein S., Grinberg A., Tran T., Shacter E., Leonardi A., Anver M., et al. Critical roles for the Bcl-3 oncoprotein in Tcell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity 1997, 6:479-490.
11. Franzoso G., Carlson L., Poljak L., Shores E.W., Epstein S., Leonardi A., Grinberg A., Tran T., Scharton-Kersten T., Anver M., et al. Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J.Exp. Med. 1998, 187:147-159.
12. Fujita T., Nolan G.P., Liou H.C., Scott M.L., Baltimore D. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. Genes Dev. 1993, 7(7B):1354-1363.
13. Griseri T., McKenzie B.S., Schiering C., Powrie F. Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity 2012, 37:1116-1129.
14. Hinz M., Arslan S.C., Scheidereit C. It takes two to tango: IκBs, the multifunctional partners of NF-κB. Immunol. Rev. 2012, 246:59-76.
15. Hirota K., Duarte J.H., Veldhoen M., Hornsby E., Li Y., Cua D.J., Ahlfors H., Wilhelm C., Tolaini M., Menzel U., et al. Fate mapping of IL-17-producing Tcells in inflammatory responses. Nat. Immunol. 2011, 12:255-263.
16. Ito H., Fathman C.G. CD45RBhigh CD4+ Tcells from IFN-gamma knockout mice do not induce wasting disease. J.Autoimmun. 1997, 10:455-459.
17. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
18. Izcue A., Hue S., Buonocore S., Arancibia-Cárcamo C.V., Ahern P.P., Iwakura Y., Maloy K.J., Powrie F. Interleukin-23 restrains regulatory Tcell activity to drive Tcell-dependent colitis. Immunity 2008, 28:559-570.
19. Kanno Y., Vahedi G., Hirahara K., Singleton K., O'Shea J.J. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu. Rev. Immunol. 2012, 30:707-731.
20. Kreisel D., Sugimoto S., Tietjens J., Zhu J., Yamamoto S., Krupnick A.S., Carmody R.J., Gelman A.E. Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis. J.Clin. Invest. 2011, 121:265-276.
21. Lazarevic V., Chen X., Shim J.H., Hwang E.S., Jang E., Bolm A.N., Oukka M., Kuchroo V.K., Glimcher L.H. T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt. Nat. Immunol. 2011, 12:96-104.
22. Lee Y.K., Turner H., Maynard C.L., Oliver J.R., Chen D., Elson C.O., Weaver C.T. Late developmental plasticity in the T helper 17 lineage. Immunity 2009, 30:92-107.
23. Maldonado V., Melendez-Zajgla J. Role of Bcl-3 in solid tumors. Mol. Cancer 2011, 10:152.
24. Marwaha A.K., Leung N.J., McMurchy A.N., Levings M.K. TH17 cells in autoimmunity and immunodeficiency: protective or pathogenic?. Front Immunol 2012, 3:129.
25. Morrison P.J., Bending D., Fouser L.A., Wright J.F., Stockinger B., Cooke A., Kullberg M.C. Th17-cell plasticity in Helicobacter hepaticus-induced intestinal inflammation. Mucosal Immunol. 2013, 6:1143-1156.
26. Mukasa R., Balasubramani A., Lee Y.K., Whitley S.K., Weaver B.T., Shibata Y., Crawford G.E., Hatton R.D., Weaver C.T. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 2010, 32:616-627.
27. Neurath M.F., Weigmann B., Finotto S., Glickman J., Nieuwenhuis E., Iijima H., Mizoguchi A., Mizoguchi E., Mudter J., Galle P.R., et al. The transcription factor T-bet regulates mucosal Tcell activation in experimental colitis and Crohn's disease. J.Exp. Med. 2002, 195:1129-1143.
28. O'Carroll C., Moloney G., Hurley G., Melgar S., Brint E., Nally K., Nibbs R.J., Shanahan F., Carmody R.J. Bcl-3 deficiency protects against dextran-sodium sulphate-induced colitis in the mouse. Clin. Exp. Immunol. 2013, 173:332-342.
29. O'Connor W., Kamanaka M., Booth C.J., Town T., Nakae S., Iwakura Y., Kolls J.K., Flavell R.A. A protective function for interleukin 17A in Tcell-mediated intestinal inflammation. Nat. Immunol. 2009, 10:603-609.
30. Ohno H., Takimoto G., McKeithan T.W. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 1990, 60:991-997.
31. Palmer S., Chen Y.H. Bcl-3, a multifaceted modulator of NF-kappaB-mediated gene transcription. Immunol. Res. 2008, 42:210-218.
32. Pène F., Paun A., Sønder S.U., Rikhi N., Wang H., Claudio E., Siebenlist U. The IκB family member Bcl-3 coordinates the pulmonary defense against Klebsiella pneumoniae infection. J.Immunol. 2011, 186:2412-2421.
33. Powrie F., Correa-Oliveira R., Mauze S., Coffman R.L. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ Tcells are important for the balance between protective and pathogenic cell-mediated immunity. J.Exp. Med. 1994, 179:589-600.
34. Powrie F., Leach M.W., Mauze S., Menon S., Caddle L.B., Coffman R.L. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ Tcells. Immunity 1994, 1:553-562.
35. Ruan Q., Zheng S.J., Palmer S., Carmody R.J., Chen Y.H. Roles of Bcl-3 in the pathogenesis of murine type 1 diabetes. Diabetes 2010, 59:2549-2557.
36. Ruan Q., Kameswaran V., Zhang Y., Zheng S., Sun J., Wang J., DeVirgiliis J., Liou H.C., Beg A.A., Chen Y.H. The Th17 immune response is controlled by the Rel-RORγ-RORγ T transcriptional axis. J.Exp. Med. 2011, 208:2321-2333.
37. Soma L.A., Gollin S.M., Remstein E.D., Ketterling R.P., Flynn H.C., Rajasenan K.K., Swerdlow S.H. Splenic small B-cell lymphoma with IGH/BCL3 translocation. Hum. Pathol. 2006, 37:218-230.
38. Tassi I., Claudio E., Wang H., Tang W., Ha H.L., Saret S., Ramaswamy M., Siegel R., Siebenlist U. The NF-κB regulator Bcl-3 governs dendritic cell antigen presentation functions in adaptive immunity. J.Immunol. 2014, Published online September 22, 2014. 10.4049/jimmunol.1401505.
39. Uhlig H.H., McKenzie B.S., Hue S., Thompson C., Joyce-Shaikh B., Stepankova R., Robinson N., Buonocore S., Tlaskalova-Hogenova H., Cua D.J., Powrie F. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 2006, 25:309-318.
40. Yen D., Cheung J., Scheerens H., Poulet F., McClanahan T., McKenzie B., Kleinschek M.A., Owyang A., Mattson J., Blumenschein W., et al. IL-23 is essential for Tcell-mediated colitis and promotes inflammation via IL-17 and IL-6. J.Clin. Invest. 2006, 116:1310-1316.
41. Zhang X., Wang H., Claudio E., Brown K., Siebenlist U. A role for the IkappaB family member Bcl-3 in the control of central immunologic tolerance. Immunity 2007, 27:438-452.
42. Zhang X., Paun A., Claudio E., Wang H., Siebenlist U. The tumor promoter and NF-κB modulator Bcl-3 regulates splenic B cell development. J.Immunol. 2013, 191:5984-5992.
43. Zhu J., Paul W.E. CD4+ Tcell plasticity-Th2 cells join the crowd. Immunity 2010, 32:11-13.